These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 1930623)

  • 41. Studies on drug release kinetics from ibuprofen-carbomer hydrophilic matrix tablets: influence of co-excipients on release rate of the drug.
    Khan GM; Zhu JB
    J Control Release; 1999 Feb; 57(2):197-203. PubMed ID: 9971903
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Matrix tablets based on a carrageenan with the modified-release of sodium riboflavin 5'-phosphate.
    Buchholcz G; Kelemen A; Sovány T; Pintye-Hódi K
    Pharm Dev Technol; 2015; 20(6):676-83. PubMed ID: 24758384
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of polymer-bound fast-dissolving metformin buccal film with disintegrants.
    Haque SE; Sheela A
    Int J Nanomedicine; 2015; 10 Suppl 1(Suppl 1):199-205. PubMed ID: 26491321
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Review of Disintegrants and the Disintegration Phenomena.
    Desai PM; Liew CV; Heng PWS
    J Pharm Sci; 2016 Sep; 105(9):2545-2555. PubMed ID: 27506604
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polymer leaching from film coating: effects on the coating transport properties.
    Marucci M; Ragnarsson G; von Corswant C; Welinder A; Jarke A; Iselau F; Axelsson A
    Int J Pharm; 2011 Jun; 411(1-2):43-8. PubMed ID: 21421031
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of formulation composition and processing on the content uniformity of low-dose tablets manufactured at kilogram scale.
    Morris DG; Truitt BF; Kong A; Leyva N; Luner PE
    Pharm Dev Technol; 2009; 14(5):451-60. PubMed ID: 19552558
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Performance of tablet disintegrants: impact of storage conditions and relative tablet density.
    Quodbach J; Kleinebudde P
    Pharm Dev Technol; 2015; 20(6):762-8. PubMed ID: 24848093
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Formulation and evaluation of mouth dissolving tablets of the Etoricoxib.
    Chandira RM; Venkataeswarlu BS; Kumudhavalli MV; Debjitbhowmik ; Jayakar B
    Pak J Pharm Sci; 2010 Apr; 23(2):178-81. PubMed ID: 20363696
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The development of Eudragit® NM-based controlled-release matrix tablets.
    Dvořáčková K; Kalėdaitė R; Gajdziok J; Rabišková M; Bajerová M; Muselík J; Lažauskas R; Pečiūra R; Bernatonienė J
    Medicina (Kaunas); 2012; 48(4):192-202. PubMed ID: 22836292
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Critical points in ethylcellulose matrices: influence of the polymer, drug and filler properties.
    Cifuentes C; Aguilar-de-Leyva A; Rajabi-Siahboomi AR; Caraballo I
    Acta Pharm; 2013 Mar; 63(1):115-29. PubMed ID: 23482317
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The influence of thermal treatment and type of insoluble poly(meth)acrylates on dissolution behavior of very soluble drug from hypromellose matrix tablets evaluated by multivariate data analysis.
    Kubova K; Peček D; Hasserová K; Doležel P; Pavelková M; Vyslouzil J; Muselík J; Vetchy D
    Pharm Dev Technol; 2017 Mar; 22(2):206-217. PubMed ID: 28058866
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of fast disintegrants in terfenadine tablets containing a gas-evolving disintegrant.
    Sallam E; Ibrahim H; Dahab RA; Shubair M; Khalil E
    Drug Dev Ind Pharm; 1998 Jun; 24(6):501-7. PubMed ID: 9876615
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The use of carrageenan in mixture with microcrystalline cellulose and its functionality for making tablets.
    Picker KM
    Eur J Pharm Biopharm; 1999 Jul; 48(1):27-36. PubMed ID: 10477325
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of polysulfonate resins and direct compression fillers on multiple-unit sustained-release dextromethorphan resinate tablets.
    Pongjanyakul T; Priprem A; Chitropas P; Puttipipatkhachorn S
    AAPS PharmSciTech; 2005 Sep; 6(2):E190-7. PubMed ID: 16353977
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of a novel drug release system, time-controlled explosion system (TES). I. Concept and design.
    Ueda S; Hata T; Asakura S; Yamaguchi H; Kotani M; Ueda Y
    J Drug Target; 1994; 2(1):35-44. PubMed ID: 8069582
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sustained-release effect of codried excipients of microcrystalline cellulose and Ganoderma fiber.
    Ke W; Ho H; Tsai T; Sheu M
    Eur J Pharm Biopharm; 2001 May; 51(3):215-9. PubMed ID: 11343885
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Release mechanism of huperzine-A swelling sustained-release tablets].
    Tang Y; Zhou W; He F; Liu C; Yang D
    Zhongguo Zhong Yao Za Zhi; 2009 Jul; 34(14):1795-8. PubMed ID: 19894509
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Xanthan gum as a rate-controlling polymer for the development of alcohol resistant matrix tablets and mini-tablets.
    Lazzari A; Kleinebudde P; Knop K
    Int J Pharm; 2018 Jan; 536(1):440-449. PubMed ID: 29225098
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of solution calorimetry in investigating controlled-release processes from polymeric drug delivery systems.
    Conti S; Gaisford S; Buckton G; Maggi L; Conte U
    Eur J Pharm Biopharm; 2008 Mar; 68(3):795-801. PubMed ID: 17646092
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of swelling/floating gastroretentive drug delivery system based on a combination of hydroxyethyl cellulose and sodium carboxymethyl cellulose for Losartan and its clinical relevance in healthy volunteers with CYP2C9 polymorphism.
    Chen RN; Ho HO; Yu CY; Sheu MT
    Eur J Pharm Sci; 2010 Jan; 39(1-3):82-9. PubMed ID: 19903527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.